Our previous studies have shown that β‐lap attenuates cisplatin‐mediated hearing impairment, by down‐regulating the acetylation of NF‐κB p65, as well as inhibiting the production of pro‐inflammatory cytokines (Kim, Oh, Shen, et al., 2014). This evidence concerns the gene NFKB1 and hearing loss disorder.